The DEC-net European register of paediatric drug therapy trials: Contents and context

European Journal of Clinical Pharmacology

Volumn 64, Issue 6, 2008, Pages 611-617

  Pandolfini, Chiara ^a   Bonati, Maurizio ^a   Rossi, Valentina ^a   Santoro, Eugenio ^a   Choonara, Imti ^b   Naylor, Coral ^b   Sammons, Helen ^b   Jacqz Aigrain, Evelyne ^c   Zarrabian, Setareh ^c   Arnau, Josep Maria ^d   Castel, Josep Maria ^d   Danés, Imma ^d   Fuentes, Inma ^d  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d Fundacion Institut Catala de Farmacologia   (Spain)

Author keywords

Biomedical research; Clinical trials; Drug therapy; Pediatrics; Registries

Indexed keywords

ABACAVIR; AGENTS ACTING ON THE GENITAL SYSTEM; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CARDIOVASCULAR AGENT; CHICKENPOX VACCINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAUNORUBICIN; DERMATOLOGICAL AGENT; DEXAMETHASONE; ETOPOSIDE; GASTROINTESTINAL AGENT; HEMATOLOGIC AGENT; INACTIVATED VACCINE; INFLIXIMAB; INFLUENZA VACCINE; LAMIVUDINE; LIVE VACCINE; METHOTREXATE; MYCOPHENOLIC ACID; NEUROTROPIC AGENT; PREDNISOLONE; PROPOFOL; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SEX HORMONE; TACROLIMUS; UNINDEXED DRUG; URINARY TRACT AGENT; VINCRISTINE;

ARTICLE; CHILD; CHILD HEALTH CARE; CLINICAL TRIAL; COOPERATION; DRUG MONITORING; EUROPE; FRANCE; HEALTH PROGRAM; HUMAN; INFORMATION RETRIEVAL; ITALY; LAW; MEDICAL LITERATURE; MEDICAL RESEARCH; NEOPLASM; PATIENT PARTICIPATION; PEDIATRICS; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; REGISTER; SPAIN; UNITED KINGDOM;

CHILD; CLINICAL TRIALS AS TOPIC; DRUG THERAPY; EUROPE; HUMANS; REGISTRIES;

EID: 42549141258     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0458-2     Document Type: Article

References (44)

1. Caldwell, PH, Murphy, SB, Butow, PN, Craig, JC (2004) Clinical trials in children. Lancet 364:803-811
2. Steinbrook R (2002) Testing medications in children. New Engl J Med 347:1462-1470
3. Choonara I, Dunne J (1998) Licensing of medicines. Arch Dis Child 78:402-403
4. Cuzzolin L, Atzei A, Fanos V (2006) Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 5:703-718
5. Pandolfini C, Bonati M (2005) A literature review on off-label drug use in children. Eur J Pediatr 164:552-558
6. Benjamin DK, Jr, Smith PB, Murphy MD, Roberts R, Mathis L, Avant D, Califf RM, Li JS (2006) Peer-reviewed publication of clinical trials completed for pediatric exclusivity. JAMA 296:1266-1273
7. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG (2004) Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291:2457-2465
8. Ioannidis JP (1998) Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 279:281-286
9. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363:1341-1345
10. Hooft L, Offringa M, Chan AW (2007) Tips and tricks for understanding and using SR results. No 5: Prospective Trial Registers. Evid Based Child Health 2:536-537
11. Bero LA (2006) Clinical trial registration at Tobacco Control. Tob Control 15:417-418
12. Clavenna A, Pandolfini C, Bonati M (2002) Public disclosure of clinical trials in children. Curr Ther Res 63:707-716
13. Hetherington J, Dickersin K, Chalmers I, Meinert CL (1989) Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatricians. Pediatrics 84:374-380
14. Antes G, Chalmers I (2003) Under-reporting of clinical trials is unethical. Lancet 361:978-979
15. Editorial (2004) The time is coming. Nat Rev Drug Discov 3:897-898
16. Bonati M (1990) Is it time for a registry of clinical trials in pediatrics? J Pediatr 116:667-668
17. Chalmers TC, Frank CS, Reitman D (1990) Minimizing the three stages of publication bias. JAMA 263:1392-1395
18. Horton R, Smith R (1999) Time to register randomised trials. The case is now unanswerable. Br Med J 319:865-866
19. Rennie D (2004) Trial registration: a great idea switches from ignored to irresistible. JAMA 292:1359-1362
20. Tonks A (1999) Registering clinical trials. Br Med J 319:1565-1568
21. Bonati M, Pandolfini C, Clavenna A (2004) Disclosure of clinical trials in children. Science 305:1401
22. Food and Drug Administration Modernization Act of 1997. Pub. L. No. 105-15, 105th Cong. Washington D.C. Passed Nov 21, 1997
23. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB (2004) Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 351:1250-1251
24. Gulmezoglu AM, Pang T, Horton R, Dickersin K (2005) WHO facilitates international collaboration in setting standards for clinical trial registration. Lancet 365:1829-1831
25. European Parliament and the Council of the European Union (2006) Regulation (EC) No 1902/2006 of the European Parliament and the Council on medicinal products for paediatric use. Published in the Official Journal of the European Union on 27/12/2006. L 378/20
26. Choonara I, Bonati M (2007) European legislation to improve medicines for children. Paediatr Perinat Dr Ther 8:2-4
27. Pandolfini C, Bonati M, Sammons H, Choonara I, Jacqz-Aigrain E, Danes I, Fuentes I, Arnau J (2003) A European clinical trials registry for children. Paediatr Perinat Dr Ther 5:98-100
28. Sammons HM, Naylor C, Choonara I, Pandolfini C, Bonati, M (2005) Should paediatricians support the European Paediatric Clinical Trials Register? Arch Dis Child 90:559-560
29. Bonati M, Pandolfini C, Rossi V, Santoro E, Arnau de Bolos JM, Danés Carreras I, Fuentes Camps I, Castel Llobet JM, Jacqz-Aigrain E, Zarrabian S, Choonara I, Sammons H, Steingo J (2004) Launch of a European paediatric clinical trials register. Paediatr Perinat Dr Ther 6:38-39
30. European Medicines Agency (EMEA) (1995) Note for guidance on general considerations for clinical trials. CPMP/ICH/291/95
31. European Medicines Agency (EMEA) (2001) ICH topic E11: Note for guidance on clinical investigation of medicinal products in the paediatric population. CPMP/ICH/2711/99 EMEA
32. Danes CI, Fuentes Camps I, Arnau de Bolos JM, Pandolfini C, Bonati M, Sammons H, Choonara I, Jacqz-Aigrain E (2004) European registry of clinical trials in children (in Spanish). An Pediatr (Barc) 60:212-214
33. Pandolfini C, Bonati M (2005) The European registry of RCT in paediatrics (in Italian). G Ital Farm Clin 19:408-410
34. Jacqz-Aigrain E, Zarrabian S, Pandolfini C, Bonati M, Sammons H, Choonara I, Danes I, Fuentes I, Arnau J (2006) A complete clinical trial register is already a reality in the paediatric field (in French). Therapie 61:121-124
35. Santoro E, Rossi V, Pandolfini C, Bonati M (2006) DEC-net: the development of the European register of clinical trials on medicines for children. Clin Trials 3:366-375
36. World Health Organization, Regional Office for Europe (2005) The European health report 2005, Public health action for healthier children and populations. Copenhagen, Denmark
37. Saint-Raymond A, Seigneuret N (2005) Medicines for children: time for Europe to act. Paediatr Perinat Dr Ther 6:142-146
38. Soteriades ES, Falagas ME (2005) Comparison of amount of biomedical research originating from the European Union and the United States. Br Med J 331:192-194
39. Remuzzi G, Schieppati A, Boissel JP, Garattini S, Horton R (2004) Independent clinical research in Europe. Lancet 364:1723-1726
40. Hain RD, Miser A, Devins M, Wallace WH (2005) Strong opioids in pediatric palliative medicine. Paediatr Drugs 7:1-9
41. Boots I, Sukhai RN, Klein RH, Holl RA, Wit JM, Cohen AF, Burggraaf J (2007) Stimulation programs for pediatric drug research-do children really benefit? Eur J Pediatr 166:849-55
42. Zimmerman R (6-2-2001) Drug makers gain by testing on kids. The Wall Street Journal Europe
43. Kaitin KI (ed) (2005) U.S. pediatric studies incentive led to new labeling for nearly 100 drugs. Tufts Center for the Study of Drug Development Impact Report. Tufts Univesity, Boston, MA
44. Li JS, Eisenstein EL, Grabowski HG, Reid ED, Mangum B, Schulman KA, Goldsmith JV, Murphy MD, Califf RM, Benjamin DK Jr (2007) Economic return of clinical trials performed under the pediatric exclusivity program. JAMA 297:480-488